• Event Type: Analyst/Institutional Investor meetings comprising both group and one-on-one formats at various conferences and forums.
  • Meeting Schedule:
  • August 12, 2026: Emkay Confluence 2026 in Mumbai (Physical)
  • August 17, 2026: Motilal Oswal 22nd Annual Investor Conference 2026 in Mumbai (Physical)
  • September 1, 2026: Elara India Dialogue 2026 in Mumbai (Physical)
  • September 17, 2026: Kotak Healthcare Forum in Mumbai (Physical)
  • Purpose: The meetings are scheduled as part of regular investor engagement activities through conference participation.
  • UPSI Disclosure: The company explicitly states that no Unpublished Price Sensitive Information (UPSI) will be disclosed during these meetings.
  • Management Participants: Not specified in this intimation.
  • Presentation Materials: No mention of presentation decks, transcripts, or recordings being made available.

Additional Notes Section

  • Compliance Basis: This intimation is made pursuant to the relevant provisions of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
  • Financial Data: No financial data, results, or guidance figures were disclosed in this announcement.
  • Schedule Flexibility: The company notes that the meeting schedule is subject to change due to exigencies on the part of either the investor or the company.
  • Attachments: No attachments were mentioned in this disclosure.